IGF-1R targeting in cancer – does sub-cellular localization matter?

Abstract The insulin-like growth factor receptor (IGF-1R) was among the most intensively pursued kinase targets in oncology. However, even after a slew of small-molecule and antibody therapeutics reached clinical trials for a range of solid tumors, the initial promise remains unfulfilled. Mechanisms...

Full description

Bibliographic Details
Main Authors: Upendra K. Soni, Liam Jenny, Rashmi S. Hegde
Format: Article
Language:English
Published: BMC 2023-10-01
Series:Journal of Experimental & Clinical Cancer Research
Subjects:
Online Access:https://doi.org/10.1186/s13046-023-02850-7